CAMBRIDGE, Mass.--(BUSINESS WIRE)--
Foundation Medicine, Inc. (FMI) today announced that the company and its collaborators will present three oral and four poster presentations at the 2015 American Society of Hematology (ASH) Annual Meeting taking place December 5 - 8, 2015 in Orlando, Florida. Collectively, the presentations will focus on the application of FoundationOne® Heme to identify druggable genomic alterations, inform personalized treatment strategies and improve clinical outcomes across a broad range of sarcomas and hematologic malignancies.
Help employers find you! Check out all the jobs and post your resume.
